OTC Healthcare in the US
Euromonitor International's OTC Healthcare in the US market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 139 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC industry proves recession resistant
While the majority of consumer goods categories suffered slower growth or declining sales in 2008, the OTC industry maintained a strong growth trajectory. Poor economic conditions made consumers reconsider their spending habits, but had little impact on consumers’ overall health. The downturn in the US economy has helped the US OTC industry because OTC products present an affordable, and increasingly effective, alternative to visiting a doctor and taking prescription medications. Furthermore, the continued ageing of the US population contributed to strong demand for healthcare products as a whole, as baby boomers aimed to stave off the effects of ageing and to remain active and healthy.
Fusion of standard and herbal medicine emerges
In 2008, Bayer Aspirin and Vick’s DayQuil/NyQuil, two well-known standard OTC brands, launched brand extensions that capitalised on the growing consumer interest in regular consumption of vitamins and dietary supplements as a daily preventative measure. Bayer Aspirin with plant sterols combines the FDA approved heart disease preventative health claims of aspirin with the cholesterol lowering qualities of plant sterols. Meanwhile, the Vick’s DayQuil/NyQuil product combines FDA approved cold fighting ingredients with a dose of vitamin C, which is thought to improve the body’s immune system. These products are the latest examples of a more holistic approach to healthcare that combines a standard Rx or OTC medication with a vitamin or supplement therapy to treat a specific condition.
Private label gains share
While overall consumer healthcare spending remained strong, branded players as a whole saw slowing sales at the expense of cheaper private label competition in the latter part of the review period. Sales growth for most branded products slowed significantly in the second half of 2008, when the US economic situation became particularly acute. Private label brands are considerably cheaper, but by law must offer the same efficacy as branded products. Private label manufacturers have become especially adept at legally challenging certain brands’ market exclusivity and at replicating the packaging of national brands.
Retailers focus on consumer health
Drugstores and grocery stores with a pharmacist on staff have been taking a proactive role in shaping consumer health. In the past two years, there has been a shift in retailers’ thinking to establish themselves as a holistic wellness destination. This means making their OTC aisles easier to navigate and making the pharmacist more involved in consumers’ purchases by being available for advice. For drug retailers, this also meant stocking a better selection of niche products, like eye and mouth care. For supermarkets, the emphasis has been on integrating the pharmacy with the grocery section.
Industry growth is expected to remain dynamic
Industry growth during the forecast period is predicted to be slightly slower than that of the review period, but it will still provide strong returns. The US population’s health is expected to remain an issue, as a lifetime of poor diet and lifestyle habits will not be reversed by the recent interest in health and wellness. The ageing consumer base will also increase the proportion of Americans who are suffering from age-related health conditions. While there are likely to be fewer Rx to OTC switches in the forecast period, the potential emergence of a true behind-the-counter (BTC) category will add new and innovative ingredients to the industry.
Table of contents
OTC HEALTHCARE IN THE US : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC industry proves recession resistant
Fusion of standard and herbal medicine emerges
Private label gains share
Retailers focus on consumer health
Industry growth is expected to remain dynamic
KEY TRENDS AND DEVELOPMENTS
America is becoming less healthy
Fusion of standard and natural medicine
Behind-the-counter category emerges
US economic slowdown promotes self-medication
Private label proves to be a tenacious competitor
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - USA
ADAMS RESPIRATORY THERAPEUTICS INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Adams Respiratory Therapeutics Inc: Competitive Position 2008
BAYER CORP - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Bayer Corp: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 6 Bayer Corp: Competitive Position 2008
CHATTEM INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Chattem Inc: Key Facts
Summary 8 Chattem Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Chattem Inc: Competitive Position 2008
GENERAL NUTRITION CENTERS INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 General Nutrition Centers Inc: Key Facts
Summary 11 General Nutrition Centers Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 General Nutrition Centers Inc: Competitive Position 2008
GLAXOSMITHKLINE CONSUMER HEALTH - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 13 GlaxoSmithKline: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 GlaxoSmithKline: Competitive Position 2008
JOHNSON & JOHNSON INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Johnson & Johnson Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2008
Summary 17 Pfizer Consumer Healthcare Ltd: Competitive Position 2008
Summary 18 Johnson & Johnson Consumer Products Inc: Competitive Position 2008
Summary 19 Advanced Care Products: Competitive Position 2008
Summary 20 Neutrogena: Competitive Position 2008
MANNATECH INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Mannatech Inc: Key Facts
Summary 22 Mannatech Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 23 Mannatech Inc: Competitive Position 2008
MELALEUCA INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 24 Melaleuca Inc: Key Facts
Summary 25 Melaleuca Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 26 Melaleuca Inc: Competitive Position 2008
PROCTER & GAMBLE CO, THE - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Procter & Gamble: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 Procter & Gamble: Competitive Position 2008
WYETH CONSUMER HEALTHCARE INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Wyeth Consumer Healthcare: Key Facts
Summary 30 Wyeth Consumer Healthcare: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 31 Wyeth Consumer Healthcare: Competitive Position 2008
ANALGESICS IN THE US
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 22 Sales of Decongestants by Type: Value 2003-2008
Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN THE US
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 33 Herbal vs Standard Digestive Remedies 2003-2008
Table 34 Digestive Remedies Company Shares by Value 2004-2008
Table 35 Digestive Remedies Brand Shares by Value 2005-2008
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN THE US
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 40 Herbal vs Standard Medicated Skin Care 2003-2008
Table 41 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 42 Medicated Skin Care Company Shares by Value 2004-2008
Table 43 Medicated Skin Care Brand Shares by Value 2005-2008
Table 44 Acne Treatments Brand Shares by Value 2005-2008
Table 45 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN THE US
HEADLINES
TRENDS - VITAMINS
TRENDS – DIETARY SUPPLEMENTS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Summary 32 Dietary Supplements: Brand Ranking by Positioning 2008
SECTOR DATA
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 50 Dietary Supplements by Positioning 2006-2008
Table 51 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 52 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 53 Vitamins Brand Shares by Value 2005-2008
Table 54 Dietary Supplements Brand Shares by Value 2005-2008
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN THE US
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 57 Number of Smokers by Gender 2003-2008
Table 58 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 59 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 60 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 61 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 62 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN THE US
TRENDS
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2003-2008
Table 66 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 67 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 68 Eye Care Company Shares by Value 2004-2008
Table 69 Eye Care Brand Shares by Value 2005-2008
Table 70 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 71 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN THE US
TRENDS
SECTOR DATA
Table 72 Sales of Ear Care: Value 2003-2008
Table 73 Sales of Ear Care: % Value Growth 2003-2008
Table 74 Ear Care Company Shares by Value 2004-2008
Table 75 Ear Care Brand Shares by Value 2005-2008
Table 76 Forecast Sales of Ear Care: Value 2008-2013
Table 77 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN THE US
HEADLINES
SECTOR DATA
Table 78 Sales of Adult Mouth Care: Value 2003-2008
Table 79 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 80 Adult Mouth Care Company Shares by Value 2004-2008
Table 81 Adult Mouth Care Brand Shares by Value 2005-2008
Table 82 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 83 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN THE US
TRENDS
SECTOR DATA
Table 84 Sales of Calming and Sleeping Products: Value 2003-2008
Table 85 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 86 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 87 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 88 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 89 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN THE US
TRENDS
SECTOR DATA
Table 90 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 91 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 92 Wound Treatments Company Shares by Value 2004-2008
Table 93 Wound Treatments Brand Shares by Value 2005-2008
Table 94 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 95 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN THE US
TRENDS
SECTOR DATA
Table 96 Sales of OTC Obesity: Value 2007-2008
Table 97 Sales of OTC Obesity: % Value Growth 2007-2008
Table 98 OTC Obesity Company Shares by Value 2007-2008
Table 99 OTC Obesity Brand Shares by Value 2007-2008
Table 100 Forecast Sales of OTC Obesity: Value 2008-2013
Table 101 Forecast Sales of OTC Obesity: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION IN THE US
TRENDS
SECTOR DATA
Table 102 Sales of Emergency Contraception: Value 2006-2008
Table 103 Sales of Emergency Contraception: % Value Growth 2006-2008
Table 104 Emergency Contraception Company Shares by Value 2006-2008
Table 105 Emergency Contraception Brand Shares by Value 2006-2008
Table 106 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 107 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC TRIPTANS IN THE US
TRENDS